Diabetic ketoacidosis and cognitive impairment in children and adolescents

被引:0
|
作者
Magomedova, K. Sh. [1 ]
Bykov, Yu. V. [2 ,3 ]
Baturin, V. A. [2 ]
机构
[1] Stepnovskaya Dist Hosp, 52a Dodonova Str, Stepnoye Village 357930, Stavropol Regio, Russia
[2] Stavropol State Med Univ, 310 Mira Str, Stavropol 355017, Russia
[3] Childrens City Clin Hosp, 5 Ponomareva Str, Stavropol 355002, Russia
来源
BYULLETEN SIBIRSKOY MEDITSINY | 2023年 / 22卷 / 03期
关键词
type 1 diabetes mellitus; diabetic ketoacidosis; cognitive impairment; children and adolescents; CEREBRAL EDEMA; YOUNG-CHILDREN; OXIDATIVE STRESS; NEW-ONSET; CLINICAL PRESENTATION; PEDIATRIC-PATIENTS; UP-REGULATION; BRAIN-INJURY; MELLITUS; RATS;
D O I
10.20538/1682-0363-2023-3-132-140
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of the literature review was to highlight modern scientific sources on the formation and clinical manifestations of cognitive impairment in children and adolescents with type 1 diabetes mellitus (DM) after diabetic ketoacidosis (DKA). Type 1 DM is one of the most prevalent endocrine disorders in childhood and adolescence. DKA is the most common acute complication of type 1 DM that may cause cognitive impairment. Cerebral edema is the main cause of cerebral vascular insufficiency in patients with DKA. However, the mechanisms underlying the development of cognitive dysfunction in DKA have not been fully elucidated. The leading hypotheses include development of neuroinflammation, oxidative stress, disruption of neurogenesis, and neurodegeneration. Hypoxic - ischemic injury and changes in the brain neuroanatomy may also cause cognitive dysfunction. Disruption of some brain structures has been reported after DKA episodes, primarily affecting the white matter. Clinical studies in the pediatric population support the presence of a correlation between the severity and frequency of DKA and the severity of cognitive impairment. Cognitive dysfunction in children and adolescents after a DKA episode can manifest through decreased attention, impaired memory and executive function, and reduced IQ. The earliest possible diagnosis of cognitive impairment in pediatric patients with symptoms of DKA in the context of type 1 DM can improve the treatment prognosis for this endocrinopathy.
引用
收藏
页码:132 / 140
页数:9
相关论文
共 50 条
  • [21] Risk factors for cerebral oedema in children and adolescents with diabetic ketoacidosis
    Yaneva, Natasha Y.
    Konstantinova, Maia M.
    Iliev, Daniel I.
    BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT, 2016, 30 (06) : 1142 - 1147
  • [22] Diabetic ketoacidosis in type 1 diabetes mellitus in children and adolescents
    Kim, Minsun
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2024, 67 (05): : 335 - 341
  • [23] Diabetic ketoacidosis in children
    White, NH
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2000, 29 (04) : 657 - +
  • [24] DIABETIC KETOACIDOSIS IN CHILDREN
    ZIMMET, P
    MEDICAL JOURNAL OF AUSTRALIA, 1973, 1 (19) : 956 - 957
  • [25] Diabetic ketoacidosis in children
    Ganesh, R.
    Suresh, N.
    Ramesh, Jayanthi
    NATIONAL MEDICAL JOURNAL OF INDIA, 2006, 19 (03): : 155 - 158
  • [26] Diabetic ketoacidosis in children
    Daggett, P
    DIABETIC MEDICINE, 1998, 15 (04) : 348 - 348
  • [27] Diabetic ketoacidosis in children
    Agus, MSD
    Wolfsdorf, JI
    PEDIATRIC CLINICS OF NORTH AMERICA, 2005, 52 (04) : 1147 - +
  • [28] Transcutaneous carbon dioxide monitoring during diabetic ketoacidosis in children and adolescents
    Berkenbosch, JW
    McBride, M
    Tobias, JD
    PEDIATRIC RESEARCH, 2003, 53 (04) : 133A - 133A
  • [29] Standardization of Care for Children and Adolescents Presenting to the Emergency Department in Diabetic Ketoacidosis
    Dahl, Amanda
    Campbell, Meredith
    Muthuvel, Gajanthan
    Scanlan-Hanson, Lori
    Pittock, Siobhan
    Mannenbach, Mark
    HORMONE RESEARCH IN PAEDIATRICS, 2020, 93 : 83 - 84
  • [30] Management of Diabetic Ketoacidosis in Children and Adolescents with Type 1 Diabetes Mellitus
    Luz Castellanos
    Marwa Tuffaha
    Dorit Koren
    Lynne L. Levitsky
    Pediatric Drugs, 2020, 22 : 357 - 367